Recent developments in the pharmaceutical industry underscore the volatile nature of advancements and market dynamics affecting prominent companies. The latest updates reveal a mix of struggles and achievements that highlight how pharmaceutical giants are navigating the complexities of drug
LakeShore Biopharma Co., Ltd (NASDAQ: LSB), a prominent biopharmaceutical company, has successfully regained compliance with Nasdaq's minimum bid price requirement after experiencing non-compliance due to a prolonged period of its share price falling below $1.00. As of October 21, 2024, the company
The Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) is experiencing a transformative period marked by the recent appointment of Michelle Tarver as its new director. Tarver, a clinical ophthalmologist with extensive experience within the FDA, steps into her
The Global Plasma Protein Therapeutics Market is on a significant growth trajectory, projected to reach approximately USD 40 billion by 2030. This expansion is driven by the indispensable role that plasma protein therapies play in treating a wide array of medical conditions, such as hemophilia,
The establishment of the BioHub Maryland Training and Education Center in Montgomery County marks a pivotal moment for the biopharma industry, both locally and nationally. With a $3 million investment from Montgomery County coupled with an additional $1.25 million from the Moore-Miller
ISO 15189 accreditation provides a solid framework for quality and technical competence, thereby significantly improving laboratory patient care by establishing comprehensive standards that medical laboratories should meet. Navigate BioPharma Services, Inc.’s recent accreditation by the College of
